{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:31:01Z","timestamp":1789594261171,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,13]]},"DOI":"10.1097\/qad.0b013e3283400088","type":"journal-article","created":{"date-parts":[[2010,10,8]],"date-time":"2010-10-08T11:41:20Z","timestamp":1286538080000},"page":"2629-2637","source":"Crossref","is-referenced-by-count":48,"title":["Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients"],"prefix":"10.1097","volume":"24","author":[{"given":"Pere","family":"Domingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"Gallego-Escuredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Mar","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Villarroya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.ijo.0803698","article-title":"Lipodystrophy in HIV 1-infected patients: lessons for obesity research","volume":"31","author":"Villarroya","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1086\/505709","article-title":"Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz","volume":"194","author":"Boyd","year":"2006","journal-title":"J Infect Dis"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0192623308327119","article-title":"The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications","volume":"37","author":"Flint","year":"2009","journal-title":"Toxicol Pathol"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS"},{"key":"R6-4-20210130","doi-asserted-by":"crossref","first-page":"373524","DOI":"10.1155\/2009\/373524","article-title":"The effects of thiazolidinediones on metabolic complications and lipodystrophy in HIV-infected patients","volume":"2009","author":"Sutinen","year":"2009","journal-title":"PPAR Res"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/135965350300800507","article-title":"2003 Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors","volume":"8","author":"Mart\u00ednez","year":"2003","journal-title":"Antivir Ther"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Maratos-Flier E 2007 Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2010.02.001","article-title":"Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat","volume":"11","author":"Hondares","year":"2010","journal-title":"Cell Metab"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2337\/db08-1775","article-title":"Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21","volume":"58","author":"Mai","year":"2009","journal-title":"Diabetes"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"G\u00e4lman","year":"2008","journal-title":"Cell Metab"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1210\/jc.2009-0111","article-title":"Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man","volume":"94","author":"Christodoulides","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2265.2008.03502.x","article-title":"Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity","volume":"71","author":"Mraz","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R18-4-20210130","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating Fibroblast Growth Factor-21 (FGF-21) is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"R20-4-20210130","first-page":"1","article-title":"Revised classification system for HIV infection and expanded surveillance for case definition for AIDS among adolescents and adults.","volume":"41","year":"1993","journal-title":"Morb Mortal Wkly Rep"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ajcn\/64.5.685","article-title":"1996 A single threshold of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue","volume":"64","author":"Lemieux","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"R22-4-20210130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.qai.0000167478.28051.3a","article-title":"Redefining lipodystrophy syndrome: risks and impact on clinical decision making","volume":"39","author":"Lichtenstein","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-4-20210130","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/clinchem\/41.5.717","article-title":"Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin","volume":"41","author":"Sugiuchi","year":"1995","journal-title":"Clin Chem"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"8","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.1177\/135965350601100610","article-title":"HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1\/HAART-associated lipodystrophy","volume":"11","author":"Giralt","year":"2006","journal-title":"Antivir Ther"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1210\/jc.2008-2331","article-title":"Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects","volume":"94","author":"Li","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-4-20210130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"R30-4-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/135965350701200203","article-title":"Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy","volume":"12","author":"Moreno-Torres","year":"2007","journal-title":"Antivir Ther"},{"key":"R31-4-20210130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QAI.0b013e318074efe3","article-title":"HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients","volume":"45","author":"Mohammed","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-4-20210130","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00002030-200211080-00011","article-title":"Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy","volume":"16","author":"Sutinen","year":"2002","journal-title":"AIDS"},{"key":"R33-4-20210130","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1210\/en.2009-0119","article-title":"2009 Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver","volume":"150","author":"Hotta","year":"2009","journal-title":"Endocrinology"},{"key":"R34-4-20210130","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","article-title":"FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity","volume":"582","author":"Arner","year":"2008","journal-title":"FEBS Lett"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201011130-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T15:12:49Z","timestamp":1740582769000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201011130-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,13]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283400088","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,13]]}}}